🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Oklahoma › Oklahoma City

Qorannoo klinikaalii Myelodysplastic Syndromes Oklahoma City, OK keessatti

Qorannoo 3 Myelodysplastic Syndromes f Oklahoma City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06577441

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Oklahoma City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.